Published on 29 January 2015
2014/4 GaBI Journal Table of Contents
3.456 views
Published on 29 January 2015
3.456 views
Published on 17 December 2014
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2014.0304.036
3.810 views
Published on 16 December 2014
Author(s): Adjunct Professor Pekka Kurki, MD, PhD
biosimilars, comparability, interchangeability, prescribers, regulators
DOI: 10.5639/gabij.2015.0401.008
12.584 views
Published on 16 December 2014
Author(s): European Biopharmaceutical Enterprises
biological medicines, biosimilars, off-patent market, pricing and reimbursement policy
DOI: 10.5639/gabij.2015.0401.006
22.373 views
Published on 16 December 2014
Author(s): Debra Hoppensteadt, PhD, Jawed Fareed, PhD, Jeanine M Walenga, PhD, Josephine Cunanan, MD, Mamdouh Bakhos, MD, Nicolas Simon, MD, PhD, Vicki Escalante, BS, Professor Walter P Jeske, PhD
anticoagulation, generics, heparins, pharmacodynamics, pharmacokinetics, population
DOI: 10.5639/gabij.2015.0402.016
32.368 views
Published on 16 December 2014
Author(s): André Vidal Pinheiro, PhD, Associate Professor Valderilio Feijó Azevedo, MD, PhD, MSc, Daniele Severi Bruni, MPhil, Ronald Halbert, MD, MPH, Erik Sandorff, MA, MBA
biosimilar pharmaceuticals, discounts, drug industry, Latin America, prescribing
DOI: 10.5639/gabij.2015.0401.005
10.305 views
Published on 16 December 2014
Author(s): Barbara J van Zwieten-Boot, Marcel Hoefnagel, Peter MJM Jongen, R Martijn van der Plas
active substance, biosimilar, EMA, Europe, guidelines, regulatory
DOI: 10.5639/gabij.2015.0401.004
11.292 views
Published on 15 December 2014
Author(s): Brian Godman, BSc, PhD
Europe, generics, hospitals, procurement
DOI: 10.5639/gabij.2014.0304.037
9.243 views
Published on 12 December 2014
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2014.0304.048
6.605 views
Published on 01 December 2014
Author(s): David Lim, DPH
Australia, biosimilars, confidential information, patent, regulation, remuneration
DOI: 10.5639/gabij.2014.0304.042
9.851 views
Published on 01 December 2014
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2014.0304.046
7.531 views
Published on 28 November 2014
Author(s): René Anour, DVM
biobetter, biosimilar, competition, interchangeability, regulatory pathways
DOI: 10.5639/gabij.2014.0304.039
124.260 views